Rezolute(RZLT.US)

Event Tracking

Jan7

Rezolute's Drug Ersodetug Fails to Meet Expectations in Phase 3 Data, Hold Ratings Maintained

19:03

Rezolute Inc. Reports Results of Third-Phase Study on Congenital Hyperinsulinism

11:11

Dec16

Rezolute CEO Nevan Elam Buys Company Stocks

02:26

Rezolute Inc. CBO Buys Company Common Stock

00:36

Dec15

HC Wainwright Downgrades Rezolute's FY2030 EPS Estimate

06:45

Dec11

Wedbush Downgrades Rezolute Stock Rating to Neutral

15:45

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -18.15 M, EPS -0.1754

Sep17

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -24.39 M, EPS -0.2592

May13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -18.91 M, EPS -0.27

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change